Heatstroke may lead to chronic heart disease and obesity, mouse model suggests
Every year, more than 100,000 people are treated for heat injury in the U.S., a number that's been rising as the world ...
Kennedy Says Ultraprocessed Foods Are Driving Chronic Disease. Here’s What the Science Shows.
In a Senate hearing, Robert F. Kennedy, Jr. said that efforts to address the high rates of chronic disease need to start with ...
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Warning as chronic heart disease risk may be 'worsened' by common illness
While the project only used mice as its subjects, scientists believe that similar damage could effect 'many years in a human lifespan' ...
EurekAlert!3d
Heatstroke leads to chronic heart disease, obesity in mice
While most victims of heatstroke seem to recover in short order, a new study from University of Florida researchers reveals that a single exposure to heatstroke can lead to lasting, multi-organ damage ...
Medscape3d
Heart Disease Still Top Cause of Death
Heart disease and stroke claim more lives in the United States than all forms of cancer and accidental deaths combined, according to a new American Heart Association report.
This country approves Ozempic to reduce risk of kidney disease in diabetes patients
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...
Pharm Exec2d
FDA Approves Novo Nordisk’s Ozempic to Reduce Kidney Disease in Patients with Type 2 Diabetes, Chronic Kidney Disease
Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...